Polycythemia is an increase in the number of red blood cells in the blood. Accordingly, the treatment of polycythemia vera is mainly to reduce the consistency of the blood and prevent bleeding and clotting. One of these methods is to draw blood to reduce the number of red blood cells.

Ruxolitinib is used in the treatment of myelofibrosis - which causes scar tissue to replace bone marrow. In addition, Ruxolitinib is also used to treat patients with polycythemia vera. However, the use of Ruxolitinib may experience some unwanted side effects such as dizziness, constipation, headache... Therefore, before using it, it is necessary to carefully study and follow the doctor's instructions. treatment .